American Shared Hospital Services (AMS): EBITDA
$2.13M
Year ended 2025-12-31
$1.82M
Trailing 12 months to 2026-06-30
-33.5%
3-year compound annual growth
-12.5%
10-year compound annual growth
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.13M | -36.9% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $3.37M | -38.0% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $5.43M | -24.7% | 2025-04-04, From 2023-01-01 |
| 2022-12-31 | $7.21M | n/a | 2024-04-01, From 2022-01-01 |
| No annual figure between 2020-12-31 and 2022-12-31. | |||
| 2020-12-31 | -$2.67M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $8.88M | +3.2% | 2021-04-06, From 2019-01-01 |
| 2018-12-31 | $8.61M | -4.5% | 2020-04-03, From 2018-01-01 |
| 2017-12-31 | $9.01M | -5.6% | 2020-04-03, From 2017-01-01 |
| 2016-12-31 | $9.55M | +17.6% | 2019-03-29, From 2016-01-01 |
| 2015-12-31 | $8.12M | +32.6% | 2018-03-28, From 2015-01-01 |
| 2014-12-31 | $6.12M | -17.6% | 2017-03-27, From 2014-01-01 |
| 2013-12-31 | $7.43M | +11.0% | 2016-03-30, From 2013-01-01 |
| 2012-12-31 | $6.70M | -13.2% | 2015-04-01, From 2012-01-01 |
| 2011-12-31 | $7.72M | +14.3% | 2014-03-31, From 2011-01-01 |
| 2010-12-31 | $6.75M | -4.0% | 2013-03-29, From 2010-01-01 |
| 2009-12-31 | $7.03M | n/a | 2012-03-30, From 2009-01-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| American Shared Hospital Services (AMS) | 2025-12-31 | $2.13M | -36.9% |
| Exagen Inc. (XGN) | 2025-12-31 | -$11.97M | n/m |
| Personalis, Inc. (PSNL) | 2025-12-31 | -$78.01M | n/m |
| Biodesix Inc (BDSX) | 2025-12-31 | -$22.20M | n/m |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $22.92M | n/m |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | -$66.97M | n/m |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | -$2.04M | n/m |
| CareDx, Inc. (CDNA) | 2025-12-31 | -$15.76M | n/m |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $79.19M | +100.0% |
Compare AMS, XGN, PSNL, BDSX side by side · Screen every company in Services-Medical Laboratories ↗